185 related articles for article (PubMed ID: 12393039)
21. Multichannel intraluminal impedance in the evaluation of patients with persistent globus on proton pump inhibitor therapy.
Anandasabapathy S; Jaffin BW
Ann Otol Rhinol Laryngol; 2006 Aug; 115(8):563-70. PubMed ID: 16944654
[TBL] [Abstract][Full Text] [Related]
22. Two-year results of intermittent electrical stimulation of the lower esophageal sphincter treatment of gastroesophageal reflux disease.
Rodríguez L; Rodriguez P; Gómez B; Ayala JC; Oxenberg D; Perez-Castilla A; Netto MG; Soffer E; Boscardin WJ; Crowell MD
Surgery; 2015 Mar; 157(3):556-67. PubMed ID: 25726315
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of treatment pattern and symptom control in patients with gastroesophageal reflux disease: multihospital questionnaire survey on the current situation in Korea.
Seo SI; Bang CS; Kang HS; Choi MH; Shin WG; Jang HJ; Kim JB; Baik KH; Kae SH; Kim HY
Dis Esophagus; 2017 Oct; 30(10):1-8. PubMed ID: 28859382
[TBL] [Abstract][Full Text] [Related]
24. Esophageal motor dysfunction plays a key role in GERD with globus sensation--analysis of factors promoting resistance to PPI therapy.
Tsutsui H; Manabe N; Uno M; Imamura H; Kamada T; Kusunoki H; Shiotani A; Hata J; Harada T; Haruma K
Scand J Gastroenterol; 2012 Sep; 47(8-9):893-9. PubMed ID: 22594305
[TBL] [Abstract][Full Text] [Related]
25. Head and neck manifestations of gastroesophageal reflux disease.
Ahuja V; Yencha MW; Lassen LF
Am Fam Physician; 1999 Sep; 60(3):873-80, 885-6. PubMed ID: 10498113
[TBL] [Abstract][Full Text] [Related]
26. [Laryngeal symptoms in patients with gastroesophageal reflux diseases].
Zalesska-Krecicka M; Waśko-Czopnik D; Krecicki T; Paradowski L; Zatoński M; Horobiowska M
Otolaryngol Pol; 2003; 57(6):819-22. PubMed ID: 15049181
[TBL] [Abstract][Full Text] [Related]
27. The diagnostic value of GerdQ in subjects with atypical symptoms of gastro-esophageal reflux disease.
Norder Grusell E; Mjörnheim AC; Finizia C; Ruth M; Bergquist H
Scand J Gastroenterol; 2018; 53(10-11):1165-1170. PubMed ID: 30353750
[TBL] [Abstract][Full Text] [Related]
28. [Significance of PPI-test in the diagnosis of GERD].
Takahashi M; Nishiki R; Ichimura H; Takada H; Kuwayama H
Nihon Rinsho; 2004 Aug; 62(8):1465-74. PubMed ID: 15344536
[TBL] [Abstract][Full Text] [Related]
29. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
Inadomi JM; McIntyre L; Bernard L; Fendrick AM
Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of the addition of prokinetics for proton pump inhibitor (PPI) resistant non-erosive reflux disease (NERD) patients: significance of frequency scale for the symptom of GERD (FSSG) on decision of treatment strategy.
Miyamoto M; Manabe N; Haruma K
Intern Med; 2010; 49(15):1469-76. PubMed ID: 20686276
[TBL] [Abstract][Full Text] [Related]
31. Gastroesophageal reflux disease with laryngopharyngeal manifestation in Korea.
Park JH; Lee DH; Kim JY; Park SY; Yoon H; Park YS; Kim N; Jeong SH; Kim JW; Lee SH; Hwang JH; Jung HC
Hepatogastroenterology; 2012; 59(120):2527-9. PubMed ID: 23178619
[TBL] [Abstract][Full Text] [Related]
32. Frequency and clinical implications of supraesophageal and dyspeptic symptoms in gastroesophageal reflux disease.
Mearin F; Ponce J; Ponce M; Balboa A; Gónzalez MA; Zapardiel J
Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):665-74. PubMed ID: 22330237
[TBL] [Abstract][Full Text] [Related]
33. The GerdQ questionnaire and high resolution manometry support the hypothesis that proton pump inhibitor-responsive oesophageal eosinophilia is a GERD-related phenomenon.
Savarino EV; Tolone S; Bartolo O; de Cassan C; Caccaro R; Galeazzi F; Nicoletti L; Salvador R; Martinato M; Costantini M; Savarino V
Aliment Pharmacol Ther; 2016 Sep; 44(5):522-30. PubMed ID: 27373195
[TBL] [Abstract][Full Text] [Related]
34. Multicentre prospective study to evaluate effectiveness and safety of gel-forming and hyaluronic-acid containing chewable tablets as add-on treatment in patients with gastroesophageal reflux disease (GERD) symptoms and unsatisfying proton pump inhibitor therapy.
Gross M; Neuschwander D; Steffens L; Thomsen J; Röschmann-Doose K
BMC Gastroenterol; 2023 Sep; 23(1):304. PubMed ID: 37674104
[TBL] [Abstract][Full Text] [Related]
35. Symptoms and quality of life in underweight gastroesophageal reflux disease patients and therapeutic responses to proton pump inhibitors.
Hongo M; Miwa H; Kusano M;
J Gastroenterol Hepatol; 2012 May; 27(5):913-8. PubMed ID: 22142515
[TBL] [Abstract][Full Text] [Related]
36. The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease.
Nojkov B; Rubenstein JH; Adlis SA; Shaw MJ; Saad R; Rai J; Weinman B; Chey WD
Aliment Pharmacol Ther; 2008 Mar; 27(6):473-82. PubMed ID: 18194508
[TBL] [Abstract][Full Text] [Related]
37. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
[TBL] [Abstract][Full Text] [Related]
38. [Insufficient symptom control under long-term treatment with PPI in GERD - fact or fiction?].
Labenz J; Labenz G; Stephan D; Willeke F;
MMW Fortschr Med; 2016 May; 158 Suppl 4():7-11. PubMed ID: 27221555
[TBL] [Abstract][Full Text] [Related]
39. The yield of upper gastrointestinal endoscopy in patients with suspected reflux-related chronic ear, nose, and throat symptoms.
Poelmans J; Feenstra L; Demedts I; Rutgeerts P; Tack J
Am J Gastroenterol; 2004 Aug; 99(8):1419-26. PubMed ID: 15307853
[TBL] [Abstract][Full Text] [Related]
40. Transition zone defect associated with the response to proton pump inhibitor treatment in patients with globus sensation.
Han MS; Lee H; Jo JH; Cho IR; Park JC; Shin SK; Lee SK; Lee YC
J Gastroenterol Hepatol; 2013 Jun; 28(6):954-62. PubMed ID: 23425059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
